+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2013-05-21Number of Pages: 65

Biochip Products and Services Market - (Microarrays, Reagents, Drug Discovery, Life Science Research, IVD Tests) U.S. Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018

Table of Content
 
Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
 
Chapter 2 Executive Summary
 
Chapter 3 Market Overview
3.1 Market Dynamics
      3.1.1 Market Drivers
               3.1.1.1 Rise in the Application of Genomics and Proteomics Technologies in Cancer Research
               3.1.1.2 Growth in Drug Discovery, Personalized Medicine and Life Science Research
               3.1.1.3 Impact Analysis of Market Drivers
     3.1.2 Market Restraints
               3.1.2.1 Low Commercial Acceptability of Biochips due to Their High Cost
               3.1.2.2 Availability of Alternative Technologies such as Mass Spectrometry and Polymerase Chain Reaction (PCR)
               3.1.2.3 Impact Analysis of Market Restraints
      3.1.3 Opportunities
               3.1.3.1 New Applications of Biochips
3.2 Porter’s Five Force Analysis for U.S. Biochip Market
      3.2.1 Bargaining Power of Suppliers
      3.2.2 Bargaining Power of Buyers
      3.2.3 Threat of New Entrants
      3.2.4 Threat of Substitutes
      3.2.5 Competitive Rivalry
3.3 Market Attractiveness Analysis of U.S. Biochip Market, by Product Type
3.4 Market Size and Trends
      3.4.1 U.S. Biochip Market, 2011 – 2018 (USD Million)
 
Chapter 4 U.S. Biochip Market, by Segments
4.1 Overview
4.2 U.S. Biochip Services Market
      4.2.1 U.S. Biochip Services Market, 2010 – 2018 (USD Million)

Chapter 5 U.S. Biochip Products  Market, by Type
5.1 Overview
5.2 U.S. Microarrays Market
      5.2.1 U.S. Microarrays Market, 2010 – 2018 (USD Million)
5.3 U.S. Reagents and Other Consumables Market
      5.3.1 U.S. Reagents and Other Consumables Market, 2010 – 2018 (USD Million)
5.4 U.S. Other Biochip Products (Biochip Instruments and Software) Market
      5.4.1 U.S. Other Biochip Products Market, 2010 – 2018 (USD Million)
 
Chapter 6 The U.S. Biochip Products and Services Market, by Application
6.1 Overview
6.2 U.S. Biochip Products and Services for Drug Delivery Market
      6.2.1 U.S. Biochip Products and Services for Drug Delivery Market
6.3 U.S. Biochip Products and Services for Life Science Research Market
      6.3.1 U.S. Biochip Products and Services for Life Science Research Market
6.4 U.S. Biochip Products and Services for In Vitro Diagnostic (IVD) Testing  Market
      6.4.1 U.S Biochip Products and Services for In Vitro Diagnostic Testing Market, 2010 – 2018 (USD Million)
6.5 U.S. Biochip Products and Services for Other Applications (Disease Management, Forensic Medicine, Defense Application) Market
      6.5.1 The U.S. Biochip Products and Services for Other Applications Market, 2010 – 2018 (USD Million)
 
Chapter 7 Competitive Landscape
7.1 Biochip Industry Composition in U.S.
 
Chapter 8 Company Profiles
8.1 Abbott Laboratories
      8.1.1 Company Overview
      8.1.2 Financial Overview
      8.1.3 Business Strategy
      8.1.4 Product Portfolio
      8.1.5 Recent Developments
8.2 Affymetrix Inc.
      8.2.1 Company Overview
      8.2.2 Financial Overview
      8.2.3 Business Strategy
      8.2.4 Product Portfolio
      8.2.5 Recent Developments
8.3 Agilent Technologies
      8.3.1 Company Overview
      8.3.2 Financial Overview
      8.3.3 Business Strategy
      8.3.4 Product Portfolio
      8.3.5 Recent Developments
8.4 Beckman Coulter, Inc.
      8.4.1 Company Overview
      8.4.2 Financial Overview
      8.4.3 Business Strategies
      8.4.4 Product Portfolio
      8.4.5 Recent Developments
8.5 Illumina Incorporated
      8.5.1 Company Overview
      8.5.2 Financial Overview
      8.5.3 Business Strategies
      8.5.4 Product Portfolio
      8.5.5 Recent Developments
8.6 Life Technologies Corporation
      8.6.1 Company Overview
      8.6.2 Financial Overview
      8.6.3 Business Strategies
      8.6.4 Product Portfolio
      8.6.5 Recent Developments
8.7 GE Healthcare
      8.7.1 Company Overview
      8.7.2 Financial Overview
      8.7.3 Business Strategy
      8.7.4 Product Portfolio
      8.7.5 Recent Developments
8.8 Roche
      8.8.1 Company Overview
      8.8.2 Financial Overview
      8.8.3 Business Strategy
      8.8.4 Product Portfolio
      8.8.5 Recent Developments

List of Figures 
 
FIG. 1 Market Segmentation: U.S. Biochip Market
FIG. 2 U.S. Biochip Market, by Product Type, 2011 (USD Million)
FIG. 3 Porter’s Five Force Analysis for U.S. Biochip Market
FIG. 4 Market Attractiveness Analysis of the U.S. Biochip Market, by Product Type
FIG. 5 U.S. Biochip Market, 2010 – 2018 (USD Million)
FIG. 6 Comparative Analysis: U.S. Biochip Market, by Segments, 2011 & 2018 (Value %)
FIG. 7 U.S. Biochip Services Market, 2010 – 2018 (USD Million)
FIG. 8 Comparative Analysis: U.S. Biochip Products Market, by Type, 2011 & 2018 (Value %)
FIG. 9  U.S. Microarrays Market, 2010 – 2018 (USD Million)
FIG. 10 U.S. Reagents and Other Consumables Market, 2010 – 2018 (USD Million)
FIG. 11 U.S. Other Biochip Products Market, 2010 – 2018 (USD Million)
FIG. 12 Comparative Analysis: U.S. Biochip Products and Services Market, by Application, 2011 & 2018 (Value %)
FIG. 13 U.S. Biochip Products and Services for Drug Delivery Market, 2010 – 2018 (USD Million)
FIG. 14 U.S. Biochip Products and Services for Life Science Research Market, 2010 – 2018 (USD Million)
FIG. 15 U.S. Biochip Products and Services for In Vitro Diagnostic Testing Market, 2010 – 2018 (USD Million)
FIG. 16 U.S. Biochip Products and Services for Other Applications Market, 2010 – 2018 (USD Million)
FIG. 17 Annual Revenues: Abbott Laboratories, 2010 – 2011 (USD Million)
FIG. 18 Annual Revenues: Affymetrix Incorporated, 2010 – 2011 (USD Million)
FIG. 19 Annual Revenues: Agilent Technologies, 2010 – 2011 (USD Million)
FIG. 20 Annual Revenues: Illumina Incorporated, 2010 – 2011 (USD Million)
FIG. 21 Annual Revenues: Life Technologies Corporation, 2010 – 2011 (USD Million)
FIG. 22 Annual Revenues: GE Healthcare, 2010 – 2011 (USD Million)
FIG. 23 Annual Revenues: Roche, 2010 – 2011 (USD Million)

List of Tables
 
TABLE 1 Market Snapshot: U.S. Biochip Market
TABLE 2 Impact Analysis Of Market Drivers
TABLE 3 Impact Analysis Of Market Restraints


 
 
Back To Top